Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

Intensive Care Medicine

Volumn 25, Issue 7, 1999, Pages 717-721

  Romagnoli, C ^a   Zecca, E ^a   Vento, G ^a   De Carolis, M P ^a   Papacci, P ^a   Tortorolo, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chronic lung disease; Dexamethasone; Preterm infants

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; STEROID;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; ENDOTRACHEAL INTUBATION; FEMALE; GROWTH DISORDER; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN THERAPY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL;

ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INJECTIONS, INTRAVENOUS; LUNG DISEASES; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME;

EID: 0032790673     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050935     Document Type: Article

References (27)

1. Bancalari E (1998) Corticosteroids and neonatal chronic lung disease. Eur J Pediatr 157 [Suppl 1]:S31-S37
2. Bhuta T, Ohlsson A (1998) Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child 79:F26-F33
3. Halliday HL (1997) A review of postnatal corticosteroids for treatment and prevention of chronic lung disease in the preterm infant. Prenat Neonat Med 2: 237-248
4. Sanders RJ, Cox C, Phelps DL, Sinkin RA (1994) Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 36: 1 22-128
5. Suske G, Oestreich K, Varnholt V, Lasch R Kachel W (1996) Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants. Acta Paediatr 85: 713-718
6. Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S et al (1996) Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child 74:F33-F37
7. Rastogi A, Akintorin SM, Bez ML, Morales R Pildes RS (1996) A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 98: 204-210
8. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin HC, Chen JY et al (1997) Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 100(4). URL: http://www.pediatrics.org/cgi/content/full/100/4/e3
9. Tapia JL, Ramirez R, Cifuentes J, Fabres J, Hubner ME, Bancalari A et al (1998) The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr 132: 48-52
10. Romagnoli C, Zecca E, Tortorolo L, Vento G, Tortorolo G (1998) A scoring system to predict the evolution of respiratory distress syndrome into chronic lung disease in preterm infants. Intensive Care Med 24: 476-480
11. Palta M, Gabbert D, Fryback D, Widjaja I, Peters M, Farrel P et al (1990) Development and validation of an index for scoring base line respiratory disease in the very low birth weight neonates. Pediatrics 86: 714-721
12. Greenough A (1990) Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment. Arch Dis Child 65: 1082-1088
13. Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 276: 357-365
14. Maggio L, Gallini F, Zecca E, Vento G, Romagnoli C (1994) Gestione del fabbisogno idroelettrolitico nel neonato VLBW nella prima settimana di vita:confronto tra AGA e SGA. Riv Ital Pediatr 20: 498-504
15. Stoll BJ (1994) Epidemiology of necrotising enterocolitis. Clin Perinatol 21: 205-218
16. Tan KL (1988) Blood pressure in very low birth weight infants in the first 70 days of life. J Pediatr 112: 266-270
17. The Committee for the Classification of Retinopathy of Prematurity (1984) An international classification of retinopathy of prematurity. Arch Ophthalmol 102: 1130-1134
18. Zimmerman JJ (1995) Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 22: 429-456
19. Contreras M, Hariharan N, Lewandoski JR, Ciesielski W, Koscik R, Zimmerman JJ (1996) Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 24: 29-37
20. Vento G, Romagnoli C, Zecca E, Matassa GP, Tortorolo L, De Carolis MP et al (1997) Increased levels of soluble intracellular adhesion molecule-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary dysplasia. Prenat Neonat Med 2: 348-355
21. Groneck R Reuss D, Gotze-Speer B, Speer CP (1993) Effects of desamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 122: 938-944
22. Yoder MC, Chua R, Tepper R (1991) Effect of desamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 143: 1044-1048
23. Farnk L, Lewis PL, Sosenko IR (1985) Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 75: 569-574
24. Groneck R Speer CP (1995) Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 73:F1-F3
25. Watterberg KL, Scott SM (1995) Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 95: 120-125
26. Bloomfiled FH, Knight DB, Harding JE (1998) Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: A randomized trial. J Pediatr 133: 395-400.
27. Romagnoli C, Vento G, Zecca E, Tortorolo L, Papacci P, De Carolis MP et al (1998) II Desametazone nella prevenzione della patologia polmonare cronica del neonato pretermine: studio prospettico randomizzato. Riv Ital Pediatr 24: 283-288